Literature DB >> 15567802

Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience.

Marilyn A Roubidoux1, Michael S Sabel, Janet E Bailey, Celina G Kleer, Katherine A Klein, Mark A Helvie.   

Abstract

PURPOSE: To determine the mammographic and ultrasonographic (US) findings at cryoablation of small solitary invasive breast cancers and compare them with presence of residual malignancy after treatment.
MATERIALS AND METHODS: Institutional review board approval and informed patient consent were obtained. Nine patients with small solitary invasive breast cancers diagnosed at core biopsy were treated with US-guided cryoablation and a 2.7-mm cryoprobe. Mean cancer size was 12 mm (range, 8-18 mm); four were palpable. Tabletop argon gas-based cryoablation system with a double-freeze-thaw protocol was used to treat cancers in outpatient setting. Tumor sites were excised at lumpectomy 2-3 weeks after cryoablation. Findings at mammography and US before, during, and after cryoablation were assessed to categorize densities and masses on mammograms and masses on US images with Breast Imaging Reporting and Data System (BI-RADS); maximum cancer size was measured. Imaging findings and clinical breast examination data were compared with histologic findings from lumpectomy specimens to determine presence of intraductal or invasive cancer.
RESULTS: With US guidance, ice balls (maximal mean size, 4.4 cm) were formed around cancers. Before excision, eight patients underwent mammography; all had new focal densities (maximum size, 2.5-5.0 cm) at cancer sites. Six patients underwent preexcisional US; 100% of them had new hyperechogenicity in tissue surrounding cancer site. Seven (78%) of nine patients had no residual cancer; specimens contained fat necrosis. One patient had a small focus of invasive cancer; one had extensive multifocal ductal carcinoma in situ. Patients with BI-RADS category 1 or 2 densities on mammograms or nonpalpable tumors had no residual malignancy. No residual invasive cancer occurred in tumors 17 mm or smaller or in cancers without spiculated margins at US.
CONCLUSION: After cryoablation, there was increased echogenicity at US and increased density at mammography; these findings were observed in areas that approximated location and size of the ice ball. Tumor size, mammographic density, and US characteristics may be indicators of likelihood of complete cryoablation. (c) RSNA, 2004.

Entities:  

Mesh:

Year:  2004        PMID: 15567802     DOI: 10.1148/radiol.2333031734

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  A Pilot Study of Ultrasound-Guided Cryoablation of Invasive Ductal Carcinomas up to 15 mm With MRI Follow-Up and Subsequent Surgical Resection.

Authors:  Steven P Poplack; Gary M Levine; Lisa Henry; Wendy A Wells; F Scott Heinemann; Cheryl M Hanna; Daniel R Deneen; Tor D Tosteson; Richard J Barth
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

Review 2.  Accuracy of ultrasound-guided, large-core needle breast biopsy.

Authors:  G Schueller; C Schueller-Weidekamm; T H Helbich
Journal:  Eur Radiol       Date:  2008-04-15       Impact factor: 5.315

3.  Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis.

Authors:  Quing Zhu; Poornima U Hegde; Andrew Ricci; Mark Kane; Edward B Cronin; Yasaman Ardeshirpour; Chen Xu; Andres Aguirre; Scott H Kurtzman; Peter J Deckers; Susan H Tannenbaum
Journal:  Radiology       Date:  2010-06-22       Impact factor: 11.105

Review 4.  Percutaneous image-guided ablation of breast tumors: an overview.

Authors:  Alan A Sag; Majid Maybody; Christopher Comstock; Stephen B Solomon
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 5.  Percutaneous image-guided cryoablation: current applications and results in the oncologic field.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Nitin Ramamurthy; Guillaume Koch; Georgia Tsoumakidou; Jean Caudrelier; Francesco Arrigoni; Luigi Zugaro; Antonio Barile; Carlo Masciocchi; Afshin Gangi
Journal:  Med Oncol       Date:  2016-11-11       Impact factor: 3.064

Review 6.  Minimally invasive ablative therapies for invasive breast carcinomas: an overview of current literature.

Authors:  Stijn van Esser; Maurice A A J van den Bosch; Paul J van Diest; Willem Th M Mali; Inne H M Borel Rinkes; Richard van Hillegersberg
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.352

7.  Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number.

Authors:  Peter J Littrup; Bassel Jallad; Vinaya Vorugu; Gunnar Littrup; Brandt Currier; Mikhail George; Donald Herring
Journal:  J Vasc Interv Radiol       Date:  2009-08-19       Impact factor: 3.464

Review 8.  Cryosurgery of breast cancer.

Authors:  Lizhi Niu; Liang Zhou; Kecheng Xu
Journal:  Gland Surg       Date:  2012-08

Review 9.  Cryosurgery in the treatment of women with breast cancer-a review.

Authors:  Radoslaw Tarkowski; Marek Rzaca
Journal:  Gland Surg       Date:  2014-05

10.  Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.

Authors:  Dinesh Chandra; Arthee Jahangir; Francois Cornelis; Klara Rombauts; Lydie Meheus; Cheryl L Jorcyk; Claudia Gravekamp
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.